Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma.
about
Open pipelines for integrated tumor genome profiles reveal differences between pancreatic cancer tumors and cell linesPrognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma.Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinomaIdentification of a novel SEREX antigen family, ECSA, in esophageal squamous cell carcinoma.k-Nearest neighbor models for microarray gene expression analysis and clinical outcome prediction.Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomas.Genome-wide characterization of pancreatic adenocarcinoma patients using next generation sequencing.Nifedipine promotes the proliferation and migration of breast cancer cells.Different Array CGH profiles within hereditary breast cancer tumors associated to BRCA1 expression and overall survivalGenomic characterization of a large panel of patient-derived hepatocellular carcinoma xenograft tumor models for preclinical developmentA systematic review of humoral immune responses against tumor antigens.Identification of regions of positive selection using Shared Genomic Segment analysis.Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction.Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage library.Tobacco habituated and non-habituated subjects exhibit different mutational spectrums in head and neck squamous cell carcinoma.
P2860
Q28650700-B96430B6-DBDF-45E7-9F0B-131E0CC39E64Q30988759-B061B800-249E-4C8F-BAF1-03256912B8BEQ33482467-DE45508D-C014-4406-B201-C7D1DDB1FAAFQ33940223-565FD8CE-EBCF-4AC2-B235-874A19D6E83DQ34059963-3EC2FA1E-5EEE-4D95-AAF2-EF3F78E68AD0Q34138855-0390C71C-7468-4FD8-9311-D2D698874EE6Q34439167-B739B715-6D57-40FF-A6CD-11BBA063C16AQ34446744-B4B83FEA-1A3D-4323-AB6B-3EC270D657A3Q34600102-E150E787-34A3-4365-AF9E-D30D799E5FE8Q35958353-88D562B6-C287-4B67-B8CB-7022EA5A3EB8Q36299617-60806994-D8DC-4EC2-A7EC-9AEF67790354Q37435862-421323C5-B2B7-47A1-89F0-D38C85FB21FCQ42011407-256C8BF6-87AA-4CEE-B84E-47C3C23F8138Q49787925-9EE56D12-7335-45FA-BC84-08DA764DD3F5Q52714597-8199D0E9-18CC-433D-875C-FD2D48A194D4Q55082067-67067AF9-7591-4850-BB5A-9F835E2B8382
P2860
Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma.
@ast
Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma.
@en
Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma.
@nl
type
label
Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma.
@ast
Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma.
@en
Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma.
@nl
prefLabel
Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma.
@ast
Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma.
@en
Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma.
@nl
P2093
P1476
Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma
@en
P2093
Atsushi Takeuchi
Fumio Nomura
Hideaki Shimada
Hiroaki Takagi
Mari Kuboshima
Masaki Takiguchi
Takaki Hiwasa
Takenori Ochiai
Tooru Shiratori
Yoshihiro Nabeya
P304
P577
2007-01-01T00:00:00Z